HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-MAY-13 4KSQ
TITLE CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 445-726;
COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL
COMPND 6 ONCOGENE HOMOLOG B1;
COMPND 7 EC: 2.7.11.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BRAF, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1, P94;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9;
SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;
SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC
KEYWDS HUMAN SERINE/THERONINE PROTEIN KINASE, KINASE DRUG COMPLEX,
KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.K.YANO,O.MASANORI
REVDAT 4 28-FEB-24 4KSQ 1 REMARK SEQADV
REVDAT 3 15-NOV-17 4KSQ 1 REMARK
REVDAT 2 04-SEP-13 4KSQ 1 JRNL
REVDAT 1 24-JUL-13 4KSQ 0
JRNL AUTH M.OKANIWA,M.HIROSE,T.ARITA,M.YABUKI,A.NAKAMURA,T.TAKAGI,
JRNL AUTH 2 T.KAWAMOTO,N.UCHIYAMA,A.SUMITA,S.TSUTSUMI,T.TOTTORI,Y.INUI,
JRNL AUTH 3 B.C.SANG,J.YANO,K.AERTGEERTS,S.YOSHIDA,T.ISHIKAWA
JRNL TITL DISCOVERY OF A SELECTIVE KINASE INHIBITOR (TAK-632)
JRNL TITL 2 TARGETING PAN-RAF INHIBITION: DESIGN, SYNTHESIS, AND
JRNL TITL 3 BIOLOGICAL EVALUATION OF C-7-SUBSTITUTED 1,3-BENZOTHIAZOLE
JRNL TITL 4 DERIVATIVES.
JRNL REF J.MED.CHEM. V. 56 6478 2013
JRNL REFN ISSN 0022-2623
JRNL PMID 23906342
JRNL DOI 10.1021/JM400778D
REMARK 2
REMARK 2 RESOLUTION. 3.30 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.7.0029
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 14103
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.208
REMARK 3 R VALUE (WORKING SET) : 0.206
REMARK 3 FREE R VALUE : 0.256
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 720
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.30
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.39
REMARK 3 REFLECTION IN BIN (WORKING SET) : 963
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.61
REMARK 3 BIN R VALUE (WORKING SET) : 0.2770
REMARK 3 BIN FREE R VALUE SET COUNT : 50
REMARK 3 BIN FREE R VALUE : 0.3140
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4093
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 78
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.31
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.00000
REMARK 3 B22 (A**2) : -1.00000
REMARK 3 B33 (A**2) : 1.99000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.481
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.354
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 48.885
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4267 ; 0.006 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 4108 ; 0.001 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5771 ; 1.132 ; 1.983
REMARK 3 BOND ANGLES OTHERS (DEGREES): 9443 ; 0.692 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 509 ; 5.627 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;35.171 ;23.859
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 766 ;17.663 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;18.435 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 626 ; 0.059 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4755 ; 0.004 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 965 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 4
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 447 A 532
REMARK 3 ORIGIN FOR THE GROUP (A): 48.7258 -31.0145 13.1750
REMARK 3 T TENSOR
REMARK 3 T11: 0.1612 T22: 0.2504
REMARK 3 T33: 0.3164 T12: 0.0441
REMARK 3 T13: 0.0239 T23: 0.1109
REMARK 3 L TENSOR
REMARK 3 L11: 4.2073 L22: 2.8875
REMARK 3 L33: 7.3818 L12: 0.7895
REMARK 3 L13: 2.2681 L23: 0.3753
REMARK 3 S TENSOR
REMARK 3 S11: -0.0722 S12: -0.6364 S13: -0.3420
REMARK 3 S21: 0.2250 S22: -0.1451 S23: -0.8278
REMARK 3 S31: 0.1592 S32: 0.6046 S33: 0.2173
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 533 A 721
REMARK 3 ORIGIN FOR THE GROUP (A): 43.3556 -43.3099 -9.5136
REMARK 3 T TENSOR
REMARK 3 T11: 0.1188 T22: 0.1590
REMARK 3 T33: 0.0429 T12: -0.0253
REMARK 3 T13: -0.0062 T23: -0.0073
REMARK 3 L TENSOR
REMARK 3 L11: 1.3360 L22: 4.7522
REMARK 3 L33: 2.4277 L12: -0.9511
REMARK 3 L13: -1.6857 L23: 1.0401
REMARK 3 S TENSOR
REMARK 3 S11: 0.0913 S12: 0.1621 S13: 0.0822
REMARK 3 S21: -0.2555 S22: 0.0293 S23: -0.0200
REMARK 3 S31: -0.1986 S32: -0.0194 S33: -0.1206
REMARK 3
REMARK 3 TLS GROUP : 3
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 448 B 532
REMARK 3 ORIGIN FOR THE GROUP (A): 35.8602 -12.3685 -2.8111
REMARK 3 T TENSOR
REMARK 3 T11: 0.3023 T22: 0.1029
REMARK 3 T33: 0.3561 T12: 0.1007
REMARK 3 T13: 0.0127 T23: 0.0637
REMARK 3 L TENSOR
REMARK 3 L11: 2.2459 L22: 5.5210
REMARK 3 L33: 4.5062 L12: -0.1543
REMARK 3 L13: -0.4582 L23: -0.6112
REMARK 3 S TENSOR
REMARK 3 S11: 0.0845 S12: 0.3234 S13: 0.7758
REMARK 3 S21: -0.5527 S22: -0.3156 S23: 0.0282
REMARK 3 S31: -0.6865 S32: -0.3293 S33: 0.2311
REMARK 3
REMARK 3 TLS GROUP : 4
REMARK 3 NUMBER OF COMPONENTS GROUP : 2
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 533 B 719
REMARK 3 RESIDUE RANGE : B 901 B 901
REMARK 3 ORIGIN FOR THE GROUP (A): 20.7970 -15.7815 18.3310
REMARK 3 T TENSOR
REMARK 3 T11: 0.0907 T22: 0.0259
REMARK 3 T33: 0.0710 T12: -0.0150
REMARK 3 T13: 0.0326 T23: 0.0088
REMARK 3 L TENSOR
REMARK 3 L11: 3.8080 L22: 2.3052
REMARK 3 L33: 2.2482 L12: -1.3974
REMARK 3 L13: -0.9792 L23: 1.6213
REMARK 3 S TENSOR
REMARK 3 S11: 0.1058 S12: 0.0485 S13: -0.0556
REMARK 3 S21: 0.2169 S22: -0.0900 S23: -0.0976
REMARK 3 S31: 0.0962 S32: 0.0281 S33: -0.0158
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : WITH TLS ADDED
REMARK 4
REMARK 4 4KSQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-13.
REMARK 100 THE DEPOSITION ID IS D_1000079747.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 04-MAR-11
REMARK 200 TEMPERATURE (KELVIN) : 95
REMARK 200 PH : 8.3
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.3
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : SINGLE SI(220) CRYSTAL
REMARK 200 MONOCHROMATOR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14150
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 5.500
REMARK 200 R MERGE (I) : 0.26300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.36
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 5.60
REMARK 200 R MERGE FOR SHELL (I) : 0.86000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 64.18
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG 8000, 0.8M LICL, 100 MM TRIS
REMARK 280 PH 8.3, SITTING DROP, VAPOR DIFFUSION, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.28950
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.41450
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.41450
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.14475
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.41450
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.41450
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 108.43425
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.41450
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.41450
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.14475
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.41450
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.41450
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 108.43425
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.28950
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 442
REMARK 465 SER A 443
REMARK 465 ASP A 444
REMARK 465 SER A 445
REMARK 465 SER A 446
REMARK 465 ALA A 597
REMARK 465 THR A 598
REMARK 465 VAL A 599
REMARK 465 LYS A 600
REMARK 465 SER A 601
REMARK 465 ARG A 602
REMARK 465 TRP A 603
REMARK 465 SER A 604
REMARK 465 GLY A 605
REMARK 465 SER A 606
REMARK 465 HIS A 607
REMARK 465 GLN A 608
REMARK 465 PHE A 609
REMARK 465 GLU A 610
REMARK 465 GLN A 611
REMARK 465 LEU A 612
REMARK 465 SER A 613
REMARK 465 LYS A 722
REMARK 465 ILE A 723
REMARK 465 HIS A 724
REMARK 465 ARG A 725
REMARK 465 GLY B 442
REMARK 465 SER B 443
REMARK 465 ASP B 444
REMARK 465 SER B 445
REMARK 465 SER B 446
REMARK 465 ASP B 447
REMARK 465 ALA B 597
REMARK 465 THR B 598
REMARK 465 VAL B 599
REMARK 465 LYS B 600
REMARK 465 SER B 601
REMARK 465 ARG B 602
REMARK 465 TRP B 603
REMARK 465 SER B 604
REMARK 465 GLY B 605
REMARK 465 SER B 606
REMARK 465 HIS B 607
REMARK 465 GLN B 608
REMARK 465 PHE B 609
REMARK 465 GLU B 610
REMARK 465 GLN B 611
REMARK 465 LEU B 612
REMARK 465 SER B 613
REMARK 465 LEU B 720
REMARK 465 PRO B 721
REMARK 465 LYS B 722
REMARK 465 ILE B 723
REMARK 465 HIS B 724
REMARK 465 ARG B 725
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 521 CG CD CE NZ
REMARK 470 PHE B 467 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 LYS B 521 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 485 48.18 -97.66
REMARK 500 ARG A 574 -17.09 74.68
REMARK 500 ASP A 575 50.33 -151.51
REMARK 500 LEU A 583 79.51 -101.86
REMARK 500 ASP A 586 19.93 52.15
REMARK 500 LEU A 587 -54.61 -136.51
REMARK 500 MET A 626 58.85 38.79
REMARK 500 ASP A 628 -153.35 -100.19
REMARK 500 PHE B 467 -78.77 -69.67
REMARK 500 ASN B 485 67.34 -100.82
REMARK 500 ARG B 508 87.97 -154.09
REMARK 500 ILE B 542 -76.41 -107.01
REMARK 500 ASP B 575 52.21 -166.99
REMARK 500 GLU B 585 25.73 48.92
REMARK 500 LEU B 587 -29.61 -149.62
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1SW A 901
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1SW B 901
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4DBN RELATED DB: PDB
REMARK 900 B-RAF INHIBITOR
REMARK 900 RELATED ID: 3Q96 RELATED DB: PDB
REMARK 900 B-RAF INHIBITOR
REMARK 900 RELATED ID: 4KSP RELATED DB: PDB
REMARK 900 B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
DBREF 4KSQ A 444 725 UNP P15056 BRAF_HUMAN 445 726
DBREF 4KSQ B 444 725 UNP P15056 BRAF_HUMAN 445 726
SEQADV 4KSQ GLY A 442 UNP P15056 EXPRESSION TAG
SEQADV 4KSQ SER A 443 UNP P15056 EXPRESSION TAG
SEQADV 4KSQ GLY B 442 UNP P15056 EXPRESSION TAG
SEQADV 4KSQ SER B 443 UNP P15056 EXPRESSION TAG
SEQRES 1 A 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY
SEQRES 2 A 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE
SEQRES 3 A 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA
SEQRES 4 A 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN
SEQRES 5 A 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS
SEQRES 6 A 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER
SEQRES 7 A 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU
SEQRES 8 A 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR
SEQRES 9 A 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN
SEQRES 10 A 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE
SEQRES 11 A 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS
SEQRES 12 A 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA
SEQRES 13 A 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU
SEQRES 14 A 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL
SEQRES 15 A 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER
SEQRES 16 A 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET
SEQRES 17 A 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP
SEQRES 18 A 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO
SEQRES 19 A 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET
SEQRES 20 A 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP
SEQRES 21 A 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU
SEQRES 22 A 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG
SEQRES 1 B 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY
SEQRES 2 B 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE
SEQRES 3 B 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA
SEQRES 4 B 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN
SEQRES 5 B 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS
SEQRES 6 B 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER
SEQRES 7 B 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU
SEQRES 8 B 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR
SEQRES 9 B 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN
SEQRES 10 B 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE
SEQRES 11 B 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS
SEQRES 12 B 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA
SEQRES 13 B 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU
SEQRES 14 B 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL
SEQRES 15 B 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER
SEQRES 16 B 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET
SEQRES 17 B 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP
SEQRES 18 B 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO
SEQRES 19 B 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET
SEQRES 20 B 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP
SEQRES 21 B 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU
SEQRES 22 B 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG
HET 1SW A 901 39
HET 1SW B 901 39
HETNAM 1SW N-{7-CYANO-6-[4-FLUORO-3-({[3-(TRIFLUOROMETHYL)
HETNAM 2 1SW PHENYL]CARBAMOYL}AMINO)PHENOXY]-1,3-BENZOTHIAZOL-2-
HETNAM 3 1SW YL}CYCLOPROPANECARBOXAMIDE
FORMUL 3 1SW 2(C26 H17 F4 N5 O3 S)
HELIX 1 1 THR A 490 ARG A 505 1 16
HELIX 2 2 SER A 535 ILE A 542 1 8
HELIX 3 3 GLU A 548 LYS A 569 1 22
HELIX 4 4 LYS A 577 ASN A 579 5 3
HELIX 5 5 GLU A 585 LEU A 587 5 3
HELIX 6 6 SER A 615 MET A 619 5 5
HELIX 7 7 ALA A 620 ARG A 625 1 6
HELIX 8 8 SER A 633 GLY A 651 1 19
HELIX 9 9 ASN A 660 GLY A 671 1 12
HELIX 10 10 ASP A 676 VAL A 680 5 5
HELIX 11 11 PRO A 685 LEU A 696 1 12
HELIX 12 12 LYS A 699 ARG A 703 5 5
HELIX 13 13 LEU A 705 SER A 719 1 15
HELIX 14 14 THR B 490 ARG B 505 1 16
HELIX 15 15 LEU B 536 ILE B 542 1 7
HELIX 16 16 GLU B 548 LYS B 569 1 22
HELIX 17 17 LYS B 577 ASN B 579 5 3
HELIX 18 18 SER B 615 MET B 619 5 5
HELIX 19 19 ALA B 620 MET B 626 1 7
HELIX 20 20 SER B 633 GLY B 651 1 19
HELIX 21 21 ASN B 660 GLY B 671 1 12
HELIX 22 22 ASP B 676 VAL B 680 5 5
HELIX 23 23 PRO B 685 LEU B 696 1 12
HELIX 24 24 LYS B 699 ARG B 703 5 5
HELIX 25 25 LEU B 705 ARG B 718 1 14
SHEET 1 A 5 THR A 457 GLY A 465 0
SHEET 2 A 5 GLY A 468 LYS A 474 -1 O LYS A 472 N GLY A 459
SHEET 3 A 5 ASP A 478 MET A 483 -1 O MET A 483 N THR A 469
SHEET 4 A 5 ALA A 525 GLN A 529 -1 O THR A 528 N ALA A 480
SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527
SHEET 1 B 2 ILE A 581 HIS A 584 0
SHEET 2 B 2 THR A 588 ILE A 591 -1 O LYS A 590 N PHE A 582
SHEET 1 C 5 THR B 457 SER B 464 0
SHEET 2 C 5 THR B 469 LYS B 474 -1 O VAL B 470 N GLY B 463
SHEET 3 C 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473
SHEET 4 C 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482
SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527
SHEET 1 D 3 GLY B 533 SER B 535 0
SHEET 2 D 3 ILE B 581 HIS B 584 -1 O LEU B 583 N SER B 534
SHEET 3 D 3 THR B 588 ILE B 591 -1 N THR B 588 O HIS B 584
CISPEP 1 LYS A 521 PRO A 522 0 -0.66
CISPEP 2 LYS B 521 PRO B 522 0 -2.03
SITE 1 AC1 17 ALA A 480 LYS A 482 GLU A 500 LEU A 504
SITE 2 AC1 17 LEU A 513 ILE A 526 THR A 528 GLN A 529
SITE 3 AC1 17 TRP A 530 CYS A 531 GLY A 533 HIS A 573
SITE 4 AC1 17 PHE A 582 ILE A 591 GLY A 592 ASP A 593
SITE 5 AC1 17 PHE A 594
SITE 1 AC2 19 ALA B 480 LYS B 482 GLU B 500 LEU B 504
SITE 2 AC2 19 ILE B 512 LEU B 513 ILE B 526 THR B 528
SITE 3 AC2 19 GLN B 529 TRP B 530 CYS B 531 GLY B 533
SITE 4 AC2 19 LEU B 566 HIS B 573 PHE B 582 ILE B 591
SITE 5 AC2 19 GLY B 592 ASP B 593 PHE B 594
CRYST1 110.829 110.829 144.579 90.00 90.00 90.00 P 41 21 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009023 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009023 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006917 0.00000